Healthcare -
Biotechnology - NASDAQ - US
$ 3.475
-5.83 %
$ 295 M
Market Cap
-2.94
P/E
TERN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities TERN - Terns Pharmaceuticals, Inc.
-38 M
LAST VALUE
43.67%
2 YEAR CAGR
-51.40%
5 YEAR CAGR
0.00%
10 YEAR CAGR